Shionogi Announces Corporate Reorganization and Personnel Reassignment

OSAKA, Japan, September 22, 2022 - Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") announced that Shionogi will implement the following corporate reorganization and personnel reassignment as of October 1, 2022.


1. Corporate Reorganization (see attached organization chart)


New establishment of the Academia Collaboration Office

The Academia Collaboration Office will be newly established within the Integrated Disease Care Division to strive to resolve issues affecting society in various fields through the integration of know-how concerning industry-academia collaboration, and the further promotion of partnerships involving Shionogi’s internal value chain and academia, in the infectious disease, psychoneurological diseases and pain.


2. Personnel Reassignments (Effective; October 1, 2022)

New Position


Present Position

Healthcare Business Supervisory Unit

Senior Director,

Integrated Disease Care Division

Academia Collaboration Office

Hiroyuki Yoshida

Integrated Disease Care Division

For Further Information, Contact:

SHIONOGI Website Inquiry Form:https://www.shionogi.com/global/en/contact.html